1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. IND-SWIFT LTD.

Ind-Swift Ltd.

NSE: INDSWFTLTD | BSE: 524652

Download real time

14.08 0.34 (2.47%)

59.42% Fall from 52W High

55,848 NSE+BSE Volume

NSE 19 Mar, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
11S
11W
0O
0T
76.3

Market Cap

Below industry Median
1.2

PE TTM

Low in industry
0

PEG TTM

-0.1

Price to Book

Negative Price to Book
0.9

Beta 1Year

Low volatility


Board Meetings - Ind-Swift Ltd.

The latest board meeting for Ind-Swift Ltd. took place on 11 Feb 2025, for the purpose of Quarterly Results

Share
Ex-date Purpose Notes
11 Feb 2025 Quarterly Results -
14 Nov 2024 Quarterly Results -
13 Aug 2024 Quarterly Results -
14 May 2024 Audited Results -
14 Feb 2024 Quarterly Results (Revised)
09 Nov 2023 Quarterly Results -
10 Aug 2023 Quarterly Results -
30 May 2023 Audited Results -
13 Feb 2023 Quarterly Results -
14 Nov 2022 Quarterly Results -
09 Aug 2022 Quarterly Results -
30 May 2022 Audited Results -
14 Feb 2022 Quarterly Results -
13 Nov 2021 Quarterly Results -
14 Aug 2021 Quarterly Results -
28 Jun 2021 Audited Results -
13 Feb 2021 Quarterly Results -
11 Nov 2020 Quarterly Results -
10 Aug 2020 Quarterly Results -
27 Jun 2020 Audited Results -
13 Feb 2020 Quarterly Results -
14 Nov 2019 Quarterly Results -
10 Aug 2019 Quarterly Results -
30 May 2019 Audited Results -
11 Feb 2019 Quarterly Results -
14 Nov 2018 Quarterly Results -
14 Aug 2018 Unaudited Financial Results -
30 May 2018 Audited Results -
13 Feb 2018 Quarterly Results -
14 Dec 2017 Quarterly Results -
14 Sep 2017 Quarterly Results -
30 May 2017 Audited Results -
13 Feb 2017 Quarterly Results -
10 Nov 2016 Quarterly Results -
10 Aug 2016 Quarterly Results -
30 May 2016 Audited Results Appointment of Ms. Simrat Kaur as Company Secretary & Compliance Officer of the Company.
12 Mar 2016 Resignation of Company Secretary -
12 Feb 2016 Quarterly Results -
07 Nov 2015 Quarterly Results -
10 Aug 2015 Quarterly Results -
04 May 2015 Audited Results -
13 Feb 2015 Quarterly Results -
07 Nov 2014 Quarterly Results -
12 Aug 2014 Quarterly Results & Others Issue of shares on preferential basis to promoters against their contribution in terms of CDR package as sanctioned by the Corporate Debt Restructuring cell.
04 Jun 2014 Audited Results Adjourn board meeting from 28/05/2014.
10 Feb 2014 Quarterly Results -
11 Nov 2013 Quarterly Results -
09 Aug 2013 Quarterly Results -
28 May 2013 Audited Results -
12 Feb 2013 Quarterly Results -
07 Nov 2012 Quarterly Results -
28 Aug 2012 Audited Results (15 months)
15 May 2012 Quarterly Results -
08 Feb 2012 Quarterly Results & Others The Board has allotted 40,00,000 Equity Shares (par value Rs. 2/- each) to the Promoter Group entities upon conversion of 40,00,000 ZCOCWs (2010 Series) at a price of Rs. 40/- per Share.
14 Nov 2011 Quarterly Results -
31 Aug 2011 Audited Results & Dividend -
10 Aug 2011 Quarterly Results -
12 May 2011 Quarterly Results -
25 Mar 2011 Allotment of Equity Shares To consider the followings: 1. Allotment of Equity Shares upon conversion of Zero Coupon Convertible Warrants issued on preferential basis. 2. Allotment of Preference Shares.
11 Feb 2011 To consider the allotment of ZCCWs Inter alia, to consider the allotment of 80,00,000 Zero Coupon Convertible Warrants on preferential basis, as approved by the Shareholders at the Annual General Meeting held September 30, 2010.
29 Jan 2011 Quarterly Results -
13 Nov 2010 Quarterly Results -
06 Sep 2010 Audited Results, Dividend & Others The Board has considered the followings: 1. Preferential issue of 80,00,000 CW's to Promoters Group & other Corporate Bodies to be issued on preferential basis. 2. Issue of Preference Shares.(Revised)
28 Jul 2010 Quarterly Results -
30 Apr 2010 Quarterly Results & Others The Board has decided to convert 19,56,000 Zero Coupon Convertible Warrants, (out of 40,00,000 Warrants) allotted to Essix Biosciences Ltd. into Equal no. of Equity Shares of Rs. 2/- each.
22 Feb 2010 Allotment of Zero Coupon CW's The BoD's has allotted 40,00,000 Zero Coupon CW's on preferential basis to M/s. Essix Bio-Sciences Ltd., at a rate of Rs. 25/- per Warrant (each Conv. into one Equity Share of Rs. 2/- each).
28 Jan 2010 Quarterly Results -
30 Oct 2009 Quarterly Results -
08 Oct 2009 To approve the allotment of ZCCW's To consider and approve 40,00,000 Zero Coupon Convertible Warrants on preferential basis to M/s. Essix Bio-Sciences Ltd. as approved by the shareholders at the AGM of the Co. held on Sept 24, 2009.
31 Aug 2009 Preferential Issue The Borad has considered the Preferential Issue of 40,00,000 Convertible Warrants to promoters group to be issued on preferential basis.
30 Jul 2009 Quarterly Results -
29 Apr 2009 Quarterly Results -
29 Jan 2009 Quarterly Results -
25 Oct 2008 Quarterly Results -
29 Aug 2008 Allotment of equity shares To consider allotment of equity shares to promoters Group Company of Zero Coupon warrants into equity shares.
23 Aug 2008 Audited Results, Dividend & Others To fix the date for Annual General Meeting.
30 Jul 2008 Quarterly Results -
28 Apr 2008 Quarterly Results -
30 Jan 2008 Quarterly Results (Revised)
29 Oct 2007 Quarterly Results -
03 Sep 2007 Audited Results & Dividend -
30 Jul 2007 Quarterly Results -
30 Apr 2007 Quarterly Results -
28 Oct 2006 Quarterly Results -
31 Aug 2006 Accounts & Dividend -
29 Jul 2006 Quarterly Results -
28 Apr 2006 Quarterly Results -
30 Jan 2006 Quarterly Results -
29 Oct 2005 Quarterly Results -
20 Aug 2005 Accounts & Dividend (Revised)
30 Jul 2005 Quarterly Results -
20 Jul 2005 Allotment of equity shares To consider and approve interalia, the allotment of equity shares of the Company upon conversion of Zero Coupon optionally convertible Warrants.
30 Apr 2005 Quarterly Results -
31 Mar 2005 To consider allotment of equity shares To consider allotment of equity shares of the company upon conversion of Zero Coupon Optionally Convertible Warrants.
23 Mar 2005 Sub Division of Equity shares -
22 Jan 2005 Quarterly Results -
30 Nov 2004 Others To allot 8,50,000 warrants to promoters of the company and allotment of 6,50,000 warrants to bodies corporate convertible into equity shares at any time within 18 months.
16 Oct 2004 Others To decide the issue of further shares/warrants convertible into shares/other convertible instrument, on preferential basis.
30 Aug 2004 Accounts -
28 Jul 2004 Quarterly Results & Others Allotment of shares to the shareholders of Mukur Pharmaceuticals Co. Pvt. Ltd., & Swift Formulations Pvt. Ltd., consequent upon amalgamation with the company.